Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Leukemia » Leukemia, Lymphoid » Precursor Cell Lymphoblastic Leukemia-Lymphoma

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Leukemia, Lymphoid » Precursor Cell Lymphoblastic Leukemia-Lymphoma

Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Leukemia, Lymphoid » Precursor Cell Lymphoblastic Leukemia-Lymphoma

Description

A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.   MeSH

Subtype Terms (2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
264 drugs (133 approved, 131 experimental)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
47 drugs (28 approved, 19 experimental)


Phase 2 Indicated Drugs (92)

Phase 1 Indicated Drugs (99)


Organization Involved with Phase 4 Indications (54)

Organization Involved with Phase 3 Indications (148)

Organization Involved with Phase 2 Indications (260)

Acibadem University

Acrotech Biopharma LLC

ADC Therapeutics SARL

AIDS Malignancy Consortium

Ain Shams University

Alberta Cancer Foundation

American Cancer Society, Inc.

AO GENERIUM

Assisi Foundation

Astex Pharmaceuticals, Inc.

AstraZeneca

Australian & New Zealand Childhood Hematology & Oncology Group

Autolus Limited

Azienda Ospedaliera Antonio Cardarelli

Azienda Osperdaliera Vincenzo Cervello Divisione

Azienda ULSS 12 Veneziana

AZ Sint-Jan

Bambino Gesù Hospital and Research Institute

Baptist Health

Baylor University

Beijing Boren Hospital

Bellicum Pharmaceuticals

Betta Pharmaceuticals Co.,Ltd.

BioCryst

Bioenvision

BioLineRx, Ltd.

BioSight Ltd.

Brown University

Callisto Pharmaceuticals

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Capital Medical University

Cardiff University

Catholic University of Korea

Celator Pharmaceuticals

Celerion

Celgene

Celldex Therapeutics

Cellerant Therapeutics

Cellgenix

Centre Henri Becquerel

Centre Leon Berard

Centro Goiano de Oncologia

Cephalon

Children's Hospital Los Angeles

Chinese University of Hong Kong

Chu De Liège

CHU Hart Leveque

CHU Mont-Godinne

City of Hope National Medical Center

Colorado Blood Cancer Institute

Complessa di Ematologia and Dir Departmento

Cookies for Kids' Cancer

CZECRIN - Czech Clinical Research Infrastructure Network

Delta-Fly Pharma, Inc.

Department of Health and Human Services

Department of Health, United Kingdom

DKMS Stiftung Leben Spenden

Doris Duke Charitable Foundation

Eli Lilly

Emory University

EORTC Lung Cancer Cooperative Group

European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib

Faculdade de Medicina do ABC

Fate Therapeutics

Federal University of Rio de Janeiro

Federal University of Rio Grande do Sul

First People's Hospital of Foshan

Fondazione Giovanni Pascale

Fondazione Matilde Tettamanti Menotti De Marchi Onlus

Fortress Biotech

Free State University

Fundacao Hospital Amaral Carvalho

Fundació Sant Joan de Déu

Gateway for Cancer Research

German Cancer Research Center

German Research Foundation

Ghent University

GlaxoSmithKline

GMP BIO Co., LTD.

Gottfried Wilhelm Leibniz Universität Hannover

Government of Brazil

Government of France

Government of Japan

Government of Mexico

Government of Singapore

Government of Spain

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

Gruppo Italiano Malattie EMatologiche dell'Adulto

Guangdong Pharmaceutical University

Guangxi Medical University

Hefei University

Henan University of Traditional Chinese Medicine

Herbert Irving Comprehensive Cancer Center

Hospital Brigadeiro

Hospital de Clinicias da UICAMP

Hospital Erasto Gaertner

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Hospital Nossa Senhora da Conceicao

Hospital Santa Marcelina, Sao Paulo, Brasil

HOVON - Dutch Haemato-Oncology Association

Humboldt University

Icahn School of Medicine at Mount Sinai

Immunomedics

INC Research

Infinity Pharmaceuticals, Inc.

Inje University

Innovative Therapies For Children with Cancer Consortium

Institut de Cancérologie de la Loire (ICLN)

Institut de Cancerologie de l'Ouest Paul Papin

Institute of Hematology and Blood Transfusion, Czech Republic

Instituto de Oncologia Pediatrica - GRAACC Grupo de Apoio as Adolescente e a Crianca com Cancer - UNIFESP

Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti

Instituto Mexicano del Seguro Social

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Instituto Português de Oncologia de Lisboa

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istitutp di Ematologia ed Oncologia Medica

Janssen Pharmaceutica NV

Johns Hopkins University

Johnson and Johnson

JP Moulton Charitable Foundation

Julius-Maximilians University

Juno Therapeutics, Inc.

Juventas Therapeutics, Inc.

Keio University

Kite Pharma, Inc.

Klinika Okulistyki

Korea Research Institute of Bioscience and Biotechnology

Kyowa Hakko Kirin

Liberty Hematology and Oncology

Louisiana State University

Ludwig Maximilians University

Matinas Biopharma, Inc

Medical University of South Carolina

MedImmune

Memorial Sloan-Kettering Cancer Center

Merck

Methodist Cancer Center, Houston, Texas

Miltenyi Biotec, Inc.

MorphoSys

Mundipharma

Nanchang University

National Cancer Center, Japan

National Hospital Organisation Nagoya Medical Centre

Newcastle University

New York Medical College

Northside Hospital, Inc.

Onconova Therapeutics, Inc.

OncoTherapy Science, Inc.

Ospedale di Bergamo

Otsuka

Our Lady's Chilrden's Hospital, Ireland

Parexel

Pavlov First Saint Petersburg State Medical University

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Pharmacyclics

Polyphor Ltd.

Precision BioSciences, Inc.

Prinses Máxima Centrum

Proacta, Incorporated

Renato Melaragno

Rio de Janeiro Federal University

Roche

Rutgers University

Sanofi

Santobono - Pausilipon Hospital

Seattle Genetics

Seoul National University

Service Clinique des Maladies du Sang

Shanghai Bioray Laboratory Inc.

Shanghai Children Medicine Center

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Shenzhen BinDeBio Ltd.

Shenzhen Geno-Immune Medical Institute

Shenzhen Institute for Innovation and Translational Medicine

Singapore General Hospital

Southwest Oncology Group

Spanish Society of Pediatric Hematology and Oncology

Sponsor GmbH

Stanford University

State University of New York, Buffalo

St. Baldrick's Foundation

Syndax Pharmaceuticals

Takara Bio Inc.

Takeda

TCR2 Therapeutics

Technical University of Dresden

Texas Oncology Cancer Center

The Beijing Pregene Science and Technology Company, Ltd.

The EMMES Corporation

The Foundation Institute San Raffaele G. Giglio of Cefalù

The Korean Society of Pediatric Hematology Oncology

The Leukemia and Lymphoma Society

The Scientific and Technological Research Council of Turkey

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Tokyo Metropolitan Komagome Hospital

Universidad Autonoma de Madrid

Universidade Federal do Parana

Universita Degli Studi La Sapeinza

Universitair Ziekenhuis Gent

University of Adelaide

University of Alabama, Birmingham

University of Alberta

University of Antwerp

University of Bern

University of Birmingham

University of Bristol

University of British Columbia

University of California, Davis

University of California, Irvine

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Chicago

University of Cologne

University of Colorado

University of Colorado, Denver

University of Duesseldorf

University of Duisburg-Essen

University of Florence

University of Florida

University of Gothenburg

University of Heidelberg

University of Kansas

University of Lyon

University of Medicine and Dentistry of New Jersey

University of Nantes

University of Nebraska

University of Nice Sophia Antipolis

University of Ottawa

University of Oulu

University of Palermo

University of Perugia

University of Regensburg

University of Rennes

University of Roma La Sapienza

University of Rostock

University of Sao Paulo

University of Southern California

University of South Florida

University of Toronto

University of Tuebingen

University of Turku

University of Ulm

University of Ulsan

University of Utah

University of Valencia

University of Versailles

University of Zurich

U.O. di Ematologia- Ospedale dell'Angelo - Mestre

Vanderbilt University

Vastra Gotaland Region

Vical

Wake Forest University

Washington University in St. Louis

Wroclaw Medical University

Yeshiva University

ZNA Antwerpen

Organization Involved with Phase 1 Indications (99)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.